Table 1.
Baseline characteristics of the patients according to SARS-CoV-2 infection status
| All (N = 237) | SARS-CoV-2 (n = 26) | Non-SARS-CoV-2 (n = 211) | P | |
|---|---|---|---|---|
| Medical history and demographic characteristics | ||||
| Inclusion centre | 0.034∗ | |||
| North | 34 (14) | 3 (11.5) | 31 (14.7) | |
| Paris | 75 (32) | 14 (53.8) | 61 (28.9) | |
| South | 128 (54) | 9 (34.6) | 119 (56.4) | |
| Age, years | 66.6 ± 13.8 | 62.7 ± 13.3 | 67 ± 13.8 | 0.13 |
| Male sex | 163 (68.8) | 19 (73.1) | 144 (68.2) | 0.62 |
| Body mass index | 27 ± 4.7 | 28 ± 4.15 | 26.2 ± 4.7 | 0.07 |
| Active smoking | 72 (30.4) | 5 (19.2) | 67 (31.7) | 0.19 |
| Arterial hypertension | 117 (49.4) | 15 (57.7) | 102 (48) | 0.36 |
| Diabetes | 68 (28.7) | 14 (53.8) | 54 (25.6) | 0.003 |
| Dyslipidemia | 90 (38) | 11 (42.3) | 79 (37.4) | 0.63 |
| eGFR < 50 mL/min/m2 | 20 (8.4) | 4 (15.4) | 16 (7.6) | 0.17 |
| Respiratory disease | 21 (8.9) | 4 (15.4) | 17 (8.1) | 0.21 |
| Clinical presentation and procedural aspects | ||||
| STEMI | 116 (49) | 17 (65.4) | 99 (46.9) | 0.0761 |
| Nonobstructive coronary arteries | 21 (8.9) | 5 (19.2) | 16 (7.6) | 0.0489 |
| Cardiac arrest at presentation | 21 (8.9) | 7 (26.9) | 14 (6.6) | 0.0005 |
| Thromboaspiration | 22 (9.3) | 3 (11.5) | 19 (9) | 0.67 |
| Persistent no-reflow | 12 (5.1) | 5 (19.2) | 7 (3.3) | 0.0004 |
| D-dimer, ng/mL† | 270 [1-752] | 1340 [414-2983] | 270 [1-500] | < 0.01 |
| C-reactive protein, mg/L | 4 [2-19] | 53 [19-127] | 3 [2-8] | < 0.0001 |
| Patient outcome | ||||
| In-hospital death | 20 (8.4) | 7 (26.9) | 13 (6.2) | 0.0003 |
| In-hospital cardiac arrest | 24 (10.1) | 12 (46.2) | 12 (5.7) | < 0.0001 |
| Cardiogenic shock or heart failure | 46 (19.4) | 10 (38.5) | 36 (17.1) | 0.0091 |
Data are presented as n (%), mean ± SD, or mean [25%-75% quartile]. Bold values represent P < 0.05.
C-reactive protein, C-reactive protein; eGFR, estimated glomerular filtration rate by Modification of Diet in Renal Disease (MDRD) equation; STEMI, ST-elevation myocardial infarction.
∗
P value is given for contingency tables.
†
Available in only 74 patients (15 with and 59 without SARS-CoV-2 infection).